Invention Grant
- Patent Title: Managing therapy delivery based on physiological markers
-
Application No.: US16663023Application Date: 2019-10-24
-
Publication No.: US11376438B2Publication Date: 2022-07-05
- Inventor: Thaddeus S. Brink , Dwight E. Nelson , Xin Su , Lance Zirpel
- Applicant: Medtronic, Inc.
- Applicant Address: US MN Minneapolis
- Assignee: Medtronic, Inc.
- Current Assignee: Medtronic, Inc.
- Current Assignee Address: US MN Minneapolis
- Agency: Shumaker & Sieffert, P.A.
- Main IPC: A61N1/36
- IPC: A61N1/36 ; A61B5/20 ; A61B5/00 ; A61B5/0538 ; A61B5/11 ; A61B5/391

Abstract:
Devices, systems, and methods may manage therapy delivery to a patient based on one or more physiological markers. In some examples, a method includes detecting a physiological marker that occurs prior in time to a dysfunctional phase of a physiological cycle, wherein a dysfunctional state of the physiological cycle occurs during the dysfunctional phase without treatment, responsive to detecting the physiological marker, initiating a first phase of the physiological cycle having a duration of time. The method may also include, responsive to the first phase elapsing, controlling a therapy delivery module to deliver neurostimulation therapy during a second phase that begins prior to the dysfunctional phase, wherein the neurostimulation therapy is configured to treat the dysfunctional state.
Public/Granted literature
- US20200054878A1 MANAGING THERAPY DELIVERY BASED ON PHYSIOLOGICAL MARKERS Public/Granted day:2020-02-20
Information query